Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


16.04.2018

2 J Neural Transm (Vienna)
6 Mov Disord
1 Neurobiol Dis
3 Neurology
2 Neurosci Lett
1 PLoS One
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Neural Transm (Vienna)

  1. MIKASA M, Kanai K, Li Y, Yoshino H, et al
    COQ2 variants in Parkinson's disease and multiple system atrophy.
    J Neural Transm (Vienna). 2018 Apr 11. pii: 10.1007/s00702-018-1885.
    PubMed     Text format     Abstract available

  2. BARTOSOVA O, Bonnet C, Ulmanova O, Sima M, et al
    Correction to: Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.
    J Neural Transm (Vienna). 2018 Apr 11. pii: 10.1007/s00702-018-1884.
    PubMed     Text format     Abstract available


    Mov Disord

  3. SCOTT KM, Williams-Gray CH
    Targeting aged astrocytes may be a new therapeutic strategy in Parkinson's disease.
    Mov Disord. 2018 Apr 6. doi: 10.1002/mds.27387.
    PubMed     Text format    

  4. AMANAT M, Salehi M
    Glitazone in Parkinson's Disease.
    Mov Disord. 2018 Apr 11. doi: 10.1002/mds.27397.
    PubMed     Text format    

  5. KASTEN M, Hartmann C, Hampf J, Schaake S, et al
    Genotype-phenotype relations for the Parkinson's Disease genes Parkin, PINK1, DJ1: MDSGene Systematic Review.
    Mov Disord. 2018 Apr 11. doi: 10.1002/mds.27352.
    PubMed     Text format     Abstract available

  6. LANG AE, Espay AJ
    Disease modification in Parkinson's Disease: Current approaches, challenges, and future considerations.
    Mov Disord. 2018 Apr 11. doi: 10.1002/mds.27360.
    PubMed     Text format     Abstract available

  7. FRIEDMAN JH
    Quetiapine for Parkinson's Disease psychosis: Evidence-based medicine versus expert belief: A case study.
    Mov Disord. 2018 Apr 11. doi: 10.1002/mds.27378.
    PubMed     Text format    

  8. CONTARINO MF, Marinus J, van Hilten JJ
    Does deep brain stimulation of the subthalamic nucleus prolong survival in Parkinson's Disease?
    Mov Disord. 2018 Apr 11. doi: 10.1002/mds.27384.
    PubMed     Text format    


    Neurobiol Dis

  9. DE MIRANDA BR, Rocha EM, Bai Q, El Ayadi A, et al
    Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    Neurobiol Dis. 2018 Apr 9. pii: S0969-9961(18)30116.
    PubMed     Text format     Abstract available


    Neurology

  10. KIM IY, O'Reilly EJ, Hughes KC, Gao X, et al
    Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.
    Neurology. 2018 Apr 11. pii: WNL.0000000000005473.
    PubMed     Text format     Abstract available

  11. PAGANO G, Polychronis S, Wilson H, Giordano B, et al
    Diabetes mellitus and Parkinson disease.
    Neurology. 2018 Apr 6. pii: WNL.0000000000005475.
    PubMed     Text format     Abstract available

  12. DAS RR, Unger MM
    Diabetes and Parkinson disease: A sweet spot?
    Neurology. 2018 Apr 6. pii: WNL.0000000000005470.
    PubMed     Text format    


    Neurosci Lett

  13. CHU CT
    Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease.
    Neurosci Lett. 2018 Apr 4. pii: S0304-3940(18)30259.
    PubMed     Text format     Abstract available

  14. SHEEHAN P, Yue Z
    Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Neurosci Lett. 2018 Apr 5. pii: S0304-3940(18)30268.
    PubMed     Text format     Abstract available


    PLoS One

  15. KIM KH, Kang SY, Shin DA, Yi S, et al
    Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery.
    PLoS One. 2018;13:e0195749.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  16. WALUSINSKI O
    Jean-Martin Charcot and Parkinson's disease: Teaching and teaching materials.
    Rev Neurol (Paris). 2018 Apr 10. pii: S0035-3787(17)30675.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: